Clotrimazole
Micronized
To guarantee the highest purity and therapeutic efficacy, we adhere to strict global standards
To guarantee the highest purity and therapeutic efficacy, we adhere to strict global standards
Clotrimazole is a key Active Pharmaceutical Ingredient (API) belonging to the Broad-Spectrum Imidazole Antifungals class. It is primarily used to treat cutaneous and mucosal infections caused by fungi and yeasts. We supply Clotrimazole in its Micronized form, which is essential for achieving an increased surface area. This enhances its solubility (in formulation bases) and maximizes local bioavailability for optimal therapeutic efficacy.
Creams, ointments, topical solutions, and dusting powders.
Micronization ensures uniform and homogeneous distribution in semi-solid formulations and minimizes insoluble particles.
Vaginal tablets or inserts.
Improved flow characteristics and compatibility with solid bases aid in molding and compression processes.
Troches (lozenges) or pastilles for oral candidiasis.
High purity meets the necessary requirements for mucosal applications.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).